Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7399/fh.2017.41.4.10775 | DOI Listing |
Cureus
September 2024
Urology, Touro University California, Stockton, USA.
Cureus
September 2024
Department of Radiology and Nuclear Medicine, Jackson Memorial Hospital, Miami, USA.
Int J Dermatol
July 2024
Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ren Fail
December 2024
Hautklinik, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Calciphylaxis (CP) is a serious, potentially life-threatening disease that presents with medial calcification of small-sized vessels and painful ischemic ulcerations. Although calciphylaxis is frequently seen in patients with end-stage kidney disease on dialysis (calcific uremic arteriolopathy, CUA), there are reported cases of nonuremic calciphylaxis (NUC), which often remain undiagnosed. We conducted a retrospective chart review at our dermatological hospital and evaluated data concerning the epidemiology, comorbidities, medication, laboratory abnormalities, and therapeutic approaches of 60 patients diagnosed with calciphylaxis between 01/2012 and 12/2022.
View Article and Find Full Text PDFClin Nephrol Case Stud
December 2023
Department of Ophthalmology, and.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!